Biomedicine
Understanding the sample and the biological question.
A MEMBER OF FDB HOLDINGXPCR is a technology project rooted in biomedical engineering and information technology.
The XPCR project began in 2020 with the aim of developing a compact instrument for COVID-19 testing. The work brought together expertise in biology, optics, hardware and software. The XPCR-103 series became the physical expression of that work.
Understanding the sample and the biological question.
From a technology idea to a physical instrument.
Digital tools that connect the different elements.
Questions about XPCR, technology or collaboration? We would like to hear from you.
Send a messageFor product information, documentation and collaboration enquiries.